AAAAAA

   
Results: 1-15 |
Results: 15
A COMPARISON OF EFFICACY OF SARGRAMOSTIM (YEAST-DERIVED RHUGM-CSF) AND FILGRASTIM (BACTERIA-DERIVED RHUG-CSF) IN THE THERAPEUTIC SETTING OFCHEMOTHERAPY-INDUCED MYELOSUPPRESSION
Authors: BEVERIDGE RA MILLER JA KALES AN BINDER RA ROBERT NJ HARVEY JH WINDSOR K GORE I CANTRELL J THOMPSON KA TAYLOR WR BARNES HM SCHIFF SA SHIELDS JA CAMBARERI RJ BUTLER TP MEISTER RJ FEIGERT JM NORGARD MJ MORAES MA HELVIE WW PATTON GA MUNDY LJ HENRY D MASON B STADDON A FORD P KATCHER D HOUCK W MAJOR WB GEMMA NW KAY G PRIEST E SOWROY P BANK B LEIBACH S REISEL H GRAD G WARREN RD UENO WM SMITH LF DOBRZYNSKI RF SHERIDAN MJ
Citation: Ra. Beveridge et al., A COMPARISON OF EFFICACY OF SARGRAMOSTIM (YEAST-DERIVED RHUGM-CSF) AND FILGRASTIM (BACTERIA-DERIVED RHUG-CSF) IN THE THERAPEUTIC SETTING OFCHEMOTHERAPY-INDUCED MYELOSUPPRESSION, Cancer investigation, 16(6), 1998, pp. 366-373
RANDOMIZED TRIAL COMPARING THE TOLERABILITY OF SARGRAMOSTIM (YEAST-DERIVED RHUGM-CSF) AND FILGRASTIM (BACTERIA-DERIVED RHUG-CSF) IN CANCER-PATIENTS RECEIVING MYELOSUPPRESSIVE CHEMOTHERAPY
Authors: BEVERIDGE RA MILLER JA KALES AN BINDER RA ROBERT NJ HEISRATHEVANS J KOCZYKSCRIPKA K PASHKO S NORGARD MJ BARNES HM TAYLOR WR THOMPSON KA SMITH LF UENO WM DOBRZYNSKI RF WARREN RD KATCHER D BYRNE PJ DUNNING DM WINOKUR SH LOCKEY JL CAMBARERI RJ BUTLER TP MEISTER RJ FIEGERT JM
Citation: Ra. Beveridge et al., RANDOMIZED TRIAL COMPARING THE TOLERABILITY OF SARGRAMOSTIM (YEAST-DERIVED RHUGM-CSF) AND FILGRASTIM (BACTERIA-DERIVED RHUG-CSF) IN CANCER-PATIENTS RECEIVING MYELOSUPPRESSIVE CHEMOTHERAPY, Supportive care in cancer, 5(4), 1997, pp. 289-298
USE OF TRUQUANT BR RADIOIMMUNOASSAY FOR EARLY DETECTION OF BREAST-CANCER RECURRENCE IN PATIENTS WITH STAGE-II AND STAGE-III DISEASE
Authors: CHAN DW BEVERIDGE RA MUSS H FRITSCHE HA HORTOBAGYI G THERIAULT R KIANG D KENNEDY BJ EVELEGH M
Citation: Dw. Chan et al., USE OF TRUQUANT BR RADIOIMMUNOASSAY FOR EARLY DETECTION OF BREAST-CANCER RECURRENCE IN PATIENTS WITH STAGE-II AND STAGE-III DISEASE, Journal of clinical oncology, 15(6), 1997, pp. 2322-2328
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR INTERLEUKIN-3 FUSIONPROTEIN VERSUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTERAUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA - RESULTS OF A RANDOMIZED DOUBLE-BLIND TRIAL
Authors: VOSE JM PANDITE AN BEVERIDGE RA GELLER RB SCHUSTER MW ANDERSON JE LEMAISTRE CF AHMED T GRANENA A KEATING A RANADA JMF STIFF PJ TABBARA I LONGO W COPELAN EA NICHOLS C SMITH A TOPOLSKY DL BIERMAN PJ LEBSACK ME LANGE M GARRISON L
Citation: Jm. Vose et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR INTERLEUKIN-3 FUSIONPROTEIN VERSUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTERAUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA - RESULTS OF A RANDOMIZED DOUBLE-BLIND TRIAL, Journal of clinical oncology, 15(4), 1997, pp. 1617-1623
LONG-TERM FOLLOW-UP OF EDELFOSINE PURGING FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ACUTE-LEUKEMIA
Authors: VOGLER WR BERDEL WE WINTON EF GORDON DS GELLER RB HEFFNER LT BROCHSTEIN JA BEVERIDGE RA DALTON WS MILLER KB LAZARUS HM
Citation: Wr. Vogler et al., LONG-TERM FOLLOW-UP OF EDELFOSINE PURGING FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ACUTE-LEUKEMIA, Experimental hematology, 24(9), 1996, pp. 615-615
RANDOMIZED PHASE-II STUDY OF PIXY321 OR NEUPOGEN (RHUG-CSF) IN COMBINATION WITH DHAP AS SALVAGE THERAPY FOR LYMPHOMA
Authors: SCHUSTER MW BEVERIDGE RA SOSMAN JA MOLINA A LIEVSVELD JL BORSON R CARON D
Citation: Mw. Schuster et al., RANDOMIZED PHASE-II STUDY OF PIXY321 OR NEUPOGEN (RHUG-CSF) IN COMBINATION WITH DHAP AS SALVAGE THERAPY FOR LYMPHOMA, Blood, 86(10), 1995, pp. 204-204
PHASE-III STUDY COMPARING PIXY321 AND GM-CSF FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN PATIENTS WITH NONHODGKINS LYMPHOMA (NHL)
Authors: VOSE JM PANDITE L BEVERIDGE RA GELLER RB SCHUSTER MW ANDERSON JE LEMAISTRE CF LEBSACK ME
Citation: Jm. Vose et al., PHASE-III STUDY COMPARING PIXY321 AND GM-CSF FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN PATIENTS WITH NONHODGKINS LYMPHOMA (NHL), Blood, 86(10), 1995, pp. 3876-3876
MANAGEMENT OF RECURRENT BREAST-CANCER
Authors: ROBERT NJ BEVERIDGE RA
Citation: Nj. Robert et Ra. Beveridge, MANAGEMENT OF RECURRENT BREAST-CANCER, Obstetrics and gynecology clinics of North America, 21(4), 1994, pp. 709-719
AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) IN ACUTE-LEUKEMIA USING MARROW PURGED WITH EDELFOSINE (ET-18-OCH3)
Authors: VOGLER WR BERDEL WE DALTON WS MILLER KB LAZARUS HM BROCHSTEIN JA GELLER RB BEVERIDGE RA
Citation: Wr. Vogler et al., AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) IN ACUTE-LEUKEMIA USING MARROW PURGED WITH EDELFOSINE (ET-18-OCH3), Experimental hematology, 22(8), 1994, pp. 778-778
A COMPARISON OF EFFICACY OF GM-CSF VERSUS G-CSF IN THE THERAPEUTIC SETTING OF CHEMOTHERAPY-INDUCED NEUTROPENIA
Authors: MILLER JA BEVERIDGE RA
Citation: Ja. Miller et Ra. Beveridge, A COMPARISON OF EFFICACY OF GM-CSF VERSUS G-CSF IN THE THERAPEUTIC SETTING OF CHEMOTHERAPY-INDUCED NEUTROPENIA, Blood, 84(10), 1994, pp. 10000022-10000022
BREAST-CANCER MARKER CA549 - A MULTICENTER STUDY
Authors: CHAN DW BEVERIDGE RA BHARGAVA A WILCOX PM KENNEDY MJ SCHWARTZ MK
Citation: Dw. Chan et al., BREAST-CANCER MARKER CA549 - A MULTICENTER STUDY, American journal of clinical pathology, 101(4), 1994, pp. 465-470
PHASE-II STUDY OF FLUOROURACIL, LEUCOVORIN, AND INTERFERON ALFA-2A INMETASTATIC COLORECTAL-CARCINOMA
Authors: GREM JL JORDAN E ROBSON ME BINDER RA HAMILTON JM STEINBERG SM ARBUCK SG BEVERIDGE RA KALES AN MILLER JA WEISS RB MCATEE N CHEN A GOLDSPIEL B SOVER E ALLEGRA CJ
Citation: Jl. Grem et al., PHASE-II STUDY OF FLUOROURACIL, LEUCOVORIN, AND INTERFERON ALFA-2A INMETASTATIC COLORECTAL-CARCINOMA, Journal of clinical oncology, 11(9), 1993, pp. 1737-1745
EFFICACY AND TOLERABILITY OF IMIPENEM-CILASTATIN VERSUS CEFTAZIDIME PLUS TOBRAMYCIN AS EMPIRIC THERAPY OF PRESUMED BACTERIAL-INFECTION IN NEUTROPENIC CANCER-PATIENTS
Authors: MILLER JA BUTLER T BEVERIDGE RA KALES AN BINDER RA SMITH LJ UENO WM MILKOVICH G GOLDWATER S MARION A ERON L MANGI R BYRNES CA LISS C PASHKO S
Citation: Ja. Miller et al., EFFICACY AND TOLERABILITY OF IMIPENEM-CILASTATIN VERSUS CEFTAZIDIME PLUS TOBRAMYCIN AS EMPIRIC THERAPY OF PRESUMED BACTERIAL-INFECTION IN NEUTROPENIC CANCER-PATIENTS, Clinical therapeutics, 15(3), 1993, pp. 486-499
A RANDOMIZED TRIAL OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) AFTERPURGED AUTOLOGOUS BONE-MARROW TRANSPLANT (BMT)
Authors: MILLER CB MILLS SR BARNETT AG BEVERIDGE RA JONES RJ
Citation: Cb. Miller et al., A RANDOMIZED TRIAL OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) AFTERPURGED AUTOLOGOUS BONE-MARROW TRANSPLANT (BMT), Blood, 82(10), 1993, pp. 10000285-10000285
COMPARISON OF TOXICITIES OF G-CSF AND YEAST-DERIVED GM-CSF
Authors: BEVERIDGE RA KALES AN BINDER RA ROBERT NJ MILLER JA
Citation: Ra. Beveridge et al., COMPARISON OF TOXICITIES OF G-CSF AND YEAST-DERIVED GM-CSF, Blood, 82(10), 1993, pp. 10000495-10000495
Risultati: 1-15 |